Discovery of purinergic signalling, the initial resistance and current explosion of interest

British Journal of Pharmacology

Volumn 167, Issue 2, 2012, Pages 238-255

  Burnstock, G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

adenosine; ATP; cancer; pain; purinoceptors; stroke

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 6 ETHYL 2 PHENYL 4 PROPYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 6 N METHYLADENOSINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; AF 317491; APADENOSON; ISTRADEFYLLINE; IVERMECTIN; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; PAROXETINE; PHENYLISOPROPYLADENOSINE; PURINERGIC P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; REGADENOSON; SPINORPHIN; SURAMIN; TECADENOSON; TICAGRELOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADRENERGIC STIMULATION; ARTICLE; DRUG BIOAVAILABILITY; DRUG STABILITY; EXCITATORY JUNCTION POTENTIAL; HUMAN; IN VIVO STUDY; NEUROTRANSMISSION; NONHUMAN; POSTDOCTORAL EDUCATION; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL COMMUNICATION; ION CHANNELS; MODELS, MOLECULAR; MUSCLE, SMOOTH; NEUROTRANSMITTER AGENTS; PROTEIN CONFORMATION; RECEPTORS, PURINERGIC; RESEARCH; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84865411454     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02008.x     Document Type: Article

References (108)

1. 2Y purinoceptors? Pharmacol Ther 64: 445-475. (Pubitemid 24381231)
2. Abbracchio MP, Burnstock G, (1998). Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78: 113-145. (Pubitemid 28508403)
3. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H, (2009). Purinergic signalling in the nervous system: an overview. Trends Neurosci 32: 19-29.
4. Agboh KC, Webb TE, Evans RJ, Ennion SJ, (2004). Functional characterization of a P2X receptor from Schistosoma mansoni. J Biol Chem 279: 41650-41657. (Pubitemid 39313609)
5. Bailey MA, Shirley DG, King BF, Burnstock G, Unwin RJ, (2007). Extracellular nucleotides and renal function. In:, Alpern RJ, Herbert SCG, (eds). The Kidney: Physiology and Pathophysiology. Elsevier: San Diego, pp. 425-443.
6. Baqi Y, Lee SY, Iqbal J, Ripphausen P, Lehr A, Scheiff AB, et al,. (2010). Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. J Med Chem 53: 2076-2086.
7. Barnard EA, Burnstock G, Webb TE, (1994). G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol Sci 15: 67-70. (Pubitemid 24086940)
8. Belai A, Burnstock G, (1994). Evidence for coexistence of ATP and nitric oxide in non-adrenergic, non-cholinergic (NANC) inhibitory neurones in the rat ileum, colon and anococcygeus muscle. Cell Tissue Res 278: 197-200. (Pubitemid 24281917)
9. Bodin P, Burnstock G, (2001). Purinergic signalling: ATP release. Neurochem Res 26: 959-969. (Pubitemid 33021422)
10. Bogdanov YD, Dale L, King BF, Whittock N, Burnstock G, (1997). Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J Biol Chem 272: 12583-12590. (Pubitemid 27203352)
11. Brake AJ, Wagenbach MJ, Julius D, (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371: 519-523. (Pubitemid 24306610)
12. Burnstock G, (1958a). The effects of acetylcholine on membrane potential, spike frequency, conduction velocity and excitability in the taenia coli of the guinea-pig. J Physiol 143: 165-182.
13. Burnstock G, (1958b). The action of adrenaline on excitability and membrane potential in the taenia coli of the guinea-pig and the effect of DNP on this action and on the action of acetylcholine. J Physiol 143: 183-194.
14. Burnstock G, (1972). Purinergic nerves. Pharmacol Rev 24: 509-581.
15. Burnstock G, (1976). Do some nerve cells release more than one transmitter? Neuroscience 1: 239-248.
16. Burnstock G, (1978). A basis for distinguishing two types of purinergic receptor. In:, Straub RW, Bolis L, (eds). Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. Raven Press: New York, pp. 107-118.
17. Burnstock G, (1986). The changing face of autonomic neurotransmission. (The First von Euler Lecture in Physiology). Acta Physiol Scand 126: 67-91. (Pubitemid 16061107)
18. Burnstock G, (1987). Local control of blood pressure by purines. Blood Vessels 24: 156-160. (Pubitemid 17096545)
19. Burnstock G, (1990). Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int 17: 357-368. (Pubitemid 20252603)
20. Burnstock G, (1993). Introduction: changing face of autonomic and sensory nerves in the circulation. In:, Edvinsson L, Uddman R, (eds). Vascular Innervation and Receptor Mechanisms: New Perspectives. Academic Press Inc, USA: San Diego, pp. 1-22.
21. Burnstock G, (1996). A unifying purinergic hypothesis for the initiation of pain. Lancet 347: 1604-1605. (Pubitemid 26170881)
22. Burnstock G, (1999). Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194: 335-342. (Pubitemid 29241485)
23. Burnstock G, (2001). Purinergic signalling in gut. In:, Abbracchio MP, Williams M, (eds). Handbook of Experimental Pharmacology, Volume 151/II. Purinergic and Pyrimidinergic Signalling II-Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function. Springer-Verlag: Berlin, pp. 141-238.
24. Burnstock G, (2002). Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22: 364-373. (Pubitemid 34218740)
25. Burnstock G, (2003). Introduction: ATP and its metabolites as potent extracellular agonists. In:, Schwiebert EM, (ed.). Current Topics in Membranes, Vol. 54. Purinergic Receptors and Signalling. Academic Press: San Diego, pp. 1-27. (Pubitemid 137640245)
26. Burnstock G, (2004). A moment of excitement. Living history series. The discovery of non-adrenergic, non-cholinergic neurotransmission. Physiol News 56: 7-9.
27. Burnstock G, (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87: 659-797. (Pubitemid 47084682)
28. Burnstock G, (2008a). Purinergic signalling in atherosclerosis and restenosis. IAS website, http://www.athero.org/commentaries/comm770.pdf
29. Burnstock G, (2008b). Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7: 575-590. (Pubitemid 351927723)
30. Burnstock G, (2009a). Acupuncture: a novel hypothesis for the involvement of purinergic signalling. Med Hypotheses 73: 470-472.
31. Burnstock G, (2009b). Purinergic mechanosensory transduction and visceral pain. Mol Pain 5: 69 doi:10.1186/1744-8069-5-69.
32. Burnstock G, (2011). Therapeutic potential of purinergic signalling for diseases of the urinary tract. BJU Int 107: 192-204.
33. Burnstock G, (2012a). Targeting the visceral purinergic system for pain control. Curr Opin Pharmacol 12: 80-86.
34. Burnstock G, (2012b). Cotransmission. In:, Robertson D, Biaggioni I, Burnstock G, Low P, Paton JF, (eds). Primer of the Autonomic Nervous System, 3rd edn. Academic Press: Oxford, pp. 27-34.
35. Burnstock G, (2012c). Purinergic Signalling: its unpopular beginning, its acceptance and its exciting future. Bio Essays 34: 218-225.
36. Burnstock G, Costa M, (1975). Adrenergic Neurones: Their Organisation, Function and Development in the Peripheral Nervous System. Chapman and Hall: London, pp. 1-225.
37. Burnstock G, Holman ME, (1960). Autonomic nerve-smooth muscle transmission. Nature 187: 951-952.
38. Burnstock G, Holman ME, (1961). The transmission of excitation from autonomic nerve to smooth muscle. J Physiol 155: 115-133.
39. 2-purinoceptor? Gen Pharmacol 16: 433-440. (Pubitemid 16250911)
40. Burnstock G, Kennedy C, (2011). P2X receptors in health and disease. In:, Jacobson KA, Linden J, (eds). Purine and Pyrimidine Receptor Pharmacology. Academic Press: Burlington, pp. 333-372.
41. Burnstock G, Straub RW, (1958). A method for studying the effects of ions and drugs on the resting and action potentials in smooth muscle with external electrodes. J Physiol 140: 156-167.
42. Burnstock G, Ulrich H, (2011). Purinergic signalling in embryonic and stem cell development. Cell Mol Life Sci 68: 1369-1394.
43. Burnstock G, Verkhratsky A, (2009). Evolutionary origins of the purinergic signalling system. Acta Physiol 195: 415-447.
44. Burnstock G, Verkhratsky A, (2010a). Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis 1: e9.
45. Burnstock G, Verkhratsky A, (2010b). Vas deferens-a model used to establish sympathetic cotransmission. Trends Pharmacol Sci 31: 131-139.
46. Burnstock G, Verkhratsky A, (2012). Purinergic Signalling and the Nervous System. Springer-Verlag: Heidelberg, Berlin, pp. 1-715.
47. Burnstock G, Wong H, (1978). Comparison of the effects of ultraviolet light and purinergic nerve stimulation on the guinea-pig taenia coli. Br J Pharmacol 62: 293-302. (Pubitemid 8264365)
48. Burnstock G, Campbell G, Bennett M, Holman ME, (1964). Innervation of the guinea-pig taenia coli: are there intrinsic inhibitory nerves which are distinct from sympathetic nerves? Int J Neuropharmacol 3: 163-166.
49. Burnstock G, Campbell G, Rand MJ, (1966). The inhibitory innervation of the taenia of the guinea-pig caecum. J Physiol 182: 504-526.
50. Burnstock G, Campbell G, Satchell D, Smythe A, (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40: 668-688.
51. Burnstock G, Cocks T, Crowe R, Kasakov L, (1978). Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol 63: 125-138. (Pubitemid 8336419)
52. Burnstock G, Fredholm BB, North RA, Verkhratsky A, (2010). The birth and postnatal development of purinergic signalling. Acta Physiol 199: 93-147.
53. Burnstock G, Krügel U, Abbracchio MP, Illes P, (2011b). Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 95: 229-274.
54. Burnstock G, Verkhratsky A, Fredholm B, (2011a). Adenosine and ATP receptors in the brain. Curr Top Med Chem 11: 973-1011.
55. Cheung K-K, Chan WY, Burnstock G, (2005). Expression of P2X receptors during rat brain development and their inhibitory role on motor axon outgrowth in neural tube explant cultures. Neuroscience 133: 937-945. (Pubitemid 40814602)
56. Clark G, Roux SJ, (2009). Extracellular nucleotides: ancient signaling molecules. Plant Sci 177: 239-244.
57. Daly JW, (1985). Adenosine receptors. Adv Cyclic Nucleotide Protein Phosphorylation Res 19: 29-46.
58. Demidchik V, Nichols C, Oliynyk M, Dark A, Glover BJ, Davies JM, (2003). Is ATP a signaling agent in plants? Plant Physiol 133: 456-461. (Pubitemid 37325656)
59. Demidchik V, Shang Z, Shin R, Colaco R, Laohavisit A, Shabala S, et al,. (2011). Receptor-like activity evoked by extracellular ADP in Arabidopsis root epidermal plasma membrane. Plant Physiol 156: 1375-1385.
60. Drury AN, Szent-Györgyi A, (1929). The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol 68: 213-237.
61. Edwards FA, Gibb AJ, Colquhoun D, (1992). ATP receptor-mediated synaptic currents in the central nervous system. Nature 359: 144-147.
62. Erlinge D, Burnstock G, (2008). P2 receptors in cardiovascular physiology and disease. Purinergic Signal 4: 1-20.
63. Evans RJ, Derkach V, Surprenant A, (1992). ATP mediates fast synaptic transmission in mammalian neurons. Nature 357: 503-505.
64. Fountain SJ, Burnstock G, (2009). An evolutionary history of P2X receptors. Purinergic Signal 5: 269-272.
65. Fountain SJ, Parkinson K, Young MT, Cao L, Thompson CR, North RA, (2007). An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum. Nature 448: 200-203. (Pubitemid 47067368)
66. Fountain SJ, Cao L, Young MT, North RA, (2008). Permeation properties of a P2X receptor in the green algae Ostreococcus tauri. J Biol Chem 283: 15122-15126.
67. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J, (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552. (Pubitemid 33136237)
68. Fujii S, Sasaki H, Mikoshiba K, Kuroda Y, Yamazaki Y, Mostafa TA, et al,. (2004). A chemical LTP induced by co-activation of metabotropic and N-methyl-D-aspartate glutamate receptors in hippocampal CA1 neurons. Brain Res 999: 20-28. (Pubitemid 38121448)
69. Gachet C, (2006). Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46: 277-300. (Pubitemid 43271191)
70. Gever JR, Rothschild S, Henningsen R, Martin R, Hackos D, Panicker S, et al,. (2010). AF-353, a novel, potent orally bioavailable P2X3/P2X2/3 receptor antagonist. Br J Pharmacol 160: 1387-1398.
71. Guarnieri S, Fanà G, Rathbone MP, Mariggià MA, (2004). Cooperation in signal transduction of extracellular guanosine 5' triphosphate and nerve growth factor in neuronal differentiation of PC12 cells. Neuroscience 128: 697-712. (Pubitemid 39298423)
72. Henning RH, (1997). Purinoceptors in neuromuscular transmission. Pharmacol Ther 74: 115-128. (Pubitemid 27337357)
73. Holton P, (1959). The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 145: 494-504.
74. Höpker VH, Saffrey MJ, Burnstock G, (1996). Neurite outgrowth of striatal neurons in vitro: involvement of purines in the growth promoting effect of myenteric plexus explants. Int J Dev Neurosci 14: 439-451. (Pubitemid 26294487)
75. Hoyle CHV, (1996). Purinergic cotransmission: parasympathetic and enteric nerves. Semin Neurosci 8: 207-215. (Pubitemid 26334962)
76. Jo YH, Role LW, (2002). Cholinergic modulation of purinergic and GABAergic co-transmission at in vitro hypothalamic synapses. J Neurophysiol 88: 2501-2508. (Pubitemid 35346053)
77. 2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol 86: 291-294. (Pubitemid 13220931)
78. 4 ion channel in the closed state. Nature 460: 592-598.
79. Kim SY, Sivaguru M, Stacey G, (2006). Extracellular ATP in plants. Visualization, localization, and analysis of physiological significance in growth and signaling. Plant Physiol 142: 984-992. (Pubitemid 44764625)
80. Krügel U, Schraft T, Kittner H, Kiess W, Illes P, (2003). Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 482: 185-187. (Pubitemid 37505943)
81. Kunapuli SP, Daniel JL, (1998). P2 receptor subtypes in the cardiovascular system. Biochem J 336: 513-523.
82. Lazarowski ER, (2012). Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8: 359-373.
83. Lazarowski ER, Sesma JI, Seminario-Vidal L, Kreda SM, (2011). Molecular mechanisms of purine and pyrimidine nucleotide release. Adv Pharmacol 61: 221-261.
84. Lustig KD, Shiau AK, Brake AJ, Julius D, (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A 90: 5113-5117. (Pubitemid 23182987)
85. 1 suggests a role for nucleotide signalling in development of the chick embryo. Dev Dyn 214: 152-158. (Pubitemid 29070051)
86. Mori M, Heuss C, Gahwiler BH, Gerber U, (2001). Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures. J Physiol 535: 115-123. (Pubitemid 32782729)
87. Neary JT, Zimmermann H, (2009). Trophic functions of nucleotides in the central nervous system. Trends Neurosci 32: 189-198.
88. Orriss IR, Burnstock G, Arnett TR, (2010). Purinergic signalling and bone remodelling. Curr Opin Pharmacol 10: 322-330.
89. Poelchen W, Sieler D, Wirkner K, Illes P, (2001). Co-transmitter function of ATP in central catecholaminergic neurons of the rat. Neuroscience 102: 593-602. (Pubitemid 32175096)
90. Ralevic V, Burnstock G, (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492. (Pubitemid 28477681)
91. Rapaport E, (1983). Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 114: 279-283. (Pubitemid 13161547)
92. Richardson PJ, Brown SJ, (1987). ATP release from affinity-purified rat cholinergic nerve terminals. J Neurochem 48: 622-630. (Pubitemid 17005177)
93. Shabbir M, Burnstock G, (2009). Purinergic receptor-mediated effects of adenosine 5'-triphosphate in urological malignant diseases. Int J Urol 16: 143-150.
94. Shabbir M, Thompson CS, Jarmulowicz M, Mikhailidis DP, Burnstock G, (2008). Effect of extracellular ATP on the growth of hormone refractory prostate cancer in vivo. BJU Int 102: 108-112. (Pubitemid 351799448)
95. Silinsky EM, Hubbard JI, (1973). Release of ATP from rat motor nerve terminals. Nature 243: 404-405.
96. Silinsky EM, Gerzanich V, Vanner SM, (1992). ATP mediates excitatory synaptic transmission in mammalian neurones. Br J Pharmacol 106: 762-763.
97. Sneddon P, Burnstock G, (1984a). Inhibition of excitatory junction potentials in guinea-pig vas deferens by α,β-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol 100: 85-90. (Pubitemid 14137501)
98. Sneddon P, Burnstock G, (1984b). ATP as a co-transmitter in rat tail artery. Eur J Pharmacol 106: 149-152. (Pubitemid 15189037)
99. 2-adrenoceptors. Neuroscience 82: 511-520. (Pubitemid 27461636)
100. 3H]adenosine triphosphate: release during stimulation of enteric nerves. Science 173: 337-339.
101. 7-deficiency ameliorates accelerated nephrotoxic nephritis in mice. J Am Soc Nephrol 20: 1275-1281.
102. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K, (2004). Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45: 89-95. (Pubitemid 38076231)
103. 2X receptor for extra-cellular ATP. Nature 371: 516-519.
104. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, et al,. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324: 219-225. (Pubitemid 23170419)
105. Westfall DP, Stitzel RE, Rowe JN, (1978). The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur J Pharmacol 50: 27-38.
106. White N, Burnstock G, (2006). P2 receptors and cancer. Trends Pharmacol Sci 27: 211-217.
107. Yegutkin GG, (2008). Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783: 673-694.
108. Zimmermann H, (2006). Nucleotide signaling in nervous system development. Pflugers Arch 452: 573-588. (Pubitemid 44015092)